Attached files
| file | filename |
|---|---|
| EX-23.1 - EXHIBIT 23.1 - IOVANCE BIOTHERAPEUTICS, INC. | v443368_ex23-1.htm |
| EX-10.32 - EXHIBIT 10.32 - IOVANCE BIOTHERAPEUTICS, INC. | v443368_ex10-32.htm |
| EX-5.1 - EXHIBIT 5.1 - IOVANCE BIOTHERAPEUTICS, INC. | v443368_ex5-1.htm |
| S-1 - FORM S-1 - IOVANCE BIOTHERAPEUTICS, INC. | v443368_s1.htm |
Exhibit 99.1
Consent of Director Nominee
Lion Biopharmaceuticals, Inc. is filing a Registration Statement on Form S-1 (SEC File No. 333-________) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of Lion Biopharmaceuticals, Inc. in the Registration Statement, as may be amended from time to time. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| /s/ DR. IAIN DUKES, M.D. | ||
| Iain Dukes, M.D. | ||